822 related articles for article (PubMed ID: 16806338)
1. Toxicokinetics and biotransformation of 3-(4-methylbenzylidene)camphor in rats after oral administration.
Völkel W; Colnot T; Schauer UM; Broschard TH; Dekant W
Toxicol Appl Pharmacol; 2006 Oct; 216(2):331-8. PubMed ID: 16806338
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of 3-(4-methylbenzylidene)camphor in rats and humans after dermal application.
Schauer UM; Völkel W; Heusener A; Colnot T; Broschard TH; von Landenberg F; Dekant W
Toxicol Appl Pharmacol; 2006 Oct; 216(2):339-46. PubMed ID: 16814339
[TBL] [Abstract][Full Text] [Related]
3. [Monograph for 3-(4-methylbenzylidene)camphor (4-MBC)--HBM values for the sum of metabolites 3-(4-carboxybenzylidene)camphor (3-4CBC) and 3-(4-carboxybenzylidene)-6-hydroxycamphor (3-4 CBHC) in the urine of adults and children. Statement of the HBM Commission of the German Federal Environment Agency].
Bekanntmachung des Umweltbundesamtes
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Jan; 59(1):132-49. PubMed ID: 26721474
[TBL] [Abstract][Full Text] [Related]
4. Distribution of the UV filter 3-benzylidene camphor in rat following topical application.
Søeborg T; Ganderup NC; Kristensen JH; Bjerregaard P; Pedersen KL; Bollen P; Hansen SH; Halling-Sørensen B
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Apr; 834(1-2):117-21. PubMed ID: 16517225
[TBL] [Abstract][Full Text] [Related]
5. Toxicokinetics of tetrabromobisphenol a in humans and rats after oral administration.
Schauer UM; Völkel W; Dekant W
Toxicol Sci; 2006 May; 91(1):49-58. PubMed ID: 16481339
[TBL] [Abstract][Full Text] [Related]
6. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects.
Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T
Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733
[TBL] [Abstract][Full Text] [Related]
7. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
[TBL] [Abstract][Full Text] [Related]
8. Disposition of a low dose of 14C-bisphenol A in male rats and its main biliary excretion as BPA glucuronide.
Kurebayashi H; Betsui H; Ohno Y
Toxicol Sci; 2003 May; 73(1):17-25. PubMed ID: 12700409
[TBL] [Abstract][Full Text] [Related]
9. Metabolism and excretion of the novel antipsychotic drug ziprasidone in rats after oral administration of a mixture of 14C- and 3H-labeled ziprasidone.
Prakash C; Kamel A; Anderson W; Howard H
Drug Metab Dispos; 1997 Feb; 25(2):206-18. PubMed ID: 9029052
[TBL] [Abstract][Full Text] [Related]
10. Sunscreens in human plasma and urine after repeated whole-body topical application.
Janjua NR; Kongshoj B; Andersson AM; Wulf HC
J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):456-61. PubMed ID: 18221342
[TBL] [Abstract][Full Text] [Related]
11. A time trend of urinary 4-methylbenzylidene camphor metabolites in young adults from Germany.
Schmidtkunz C; Küpper K; Weber T; Leng G; Kolossa-Gehring M
Environ Res; 2023 Jul; 228():115833. PubMed ID: 37028537
[TBL] [Abstract][Full Text] [Related]
12. Toxicokinetics of acrylamide in rats and humans following single oral administration of low doses.
Kopp EK; Dekant W
Toxicol Appl Pharmacol; 2009 Mar; 235(2):135-42. PubMed ID: 19118568
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous determination of MK-0767 and seven metabolites in rat urine using liquid chromatography/tandem mass spectrometry.
Shen Z; Kochansky C; Bakhtiar R; Franklin RB; Vincent SH
Rapid Commun Mass Spectrom; 2004; 18(18):2113-20. PubMed ID: 15317046
[TBL] [Abstract][Full Text] [Related]
14. Biotransformation of 2,3,3,3-tetrafluoropropene (HFO-1234yf).
Schuster P; Bertermann R; Snow TA; Han X; Rusch GM; Jepson GW; Dekant W
Toxicol Appl Pharmacol; 2008 Dec; 233(2):323-32. PubMed ID: 18817801
[TBL] [Abstract][Full Text] [Related]
15. Complexation of the sunscreen agent, 4-methylbenzylidene camphor with cyclodextrins: effect on photostability and human stratum corneum penetration.
Scalia S; Tursilli R; Iannuccelli V
J Pharm Biomed Anal; 2007 May; 44(1):29-34. PubMed ID: 17291707
[TBL] [Abstract][Full Text] [Related]
16. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
Prakash C; Soliman V
Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906
[TBL] [Abstract][Full Text] [Related]
17. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans.
Prakash C; Kamel A; Gummerus J; Wilner K
Drug Metab Dispos; 1997 Jul; 25(7):863-72. PubMed ID: 9224781
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of pyridalyl in rats.
Nagahori H; Saito K; Tomigahara Y; Isobe N; Kaneko H
Drug Metab Dispos; 2009 Dec; 37(12):2284-9. PubMed ID: 19773539
[TBL] [Abstract][Full Text] [Related]
19. Influence of solid lipid microparticle carriers on skin penetration of the sunscreen agent, 4-methylbenzylidene camphor.
Scalia S; Mezzena M; Iannuccelli V
J Pharm Pharmacol; 2007 Dec; 59(12):1621-7. PubMed ID: 18053323
[TBL] [Abstract][Full Text] [Related]
20. Comparative metabolism of radiolabeled muraglitazar in animals and humans by quantitative and qualitative metabolite profiling.
Zhang D; Wang L; Raghavan N; Zhang H; Li W; Cheng PT; Yao M; Zhang L; Zhu M; Bonacorsi S; Yeola S; Mitroka J; Hariharan N; Hosagrahara V; Chandrasena G; Shyu WC; Humphreys WG
Drug Metab Dispos; 2007 Jan; 35(1):150-67. PubMed ID: 17062777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
